Corneal Defect
Showing 1 - 25 of 2,506
Corneal Edema, Corneal Defect, Anterior Chamber Inflammation Trial in Los Angeles (Dextenza 0.4Mg Ophthalmic Insert,
Not yet recruiting
- Corneal Edema
- +6 more
- Dextenza 0.4Mg Ophthalmic Insert
- +3 more
-
Los Angeles, CaliforniaAdvanced Vision Care
Dec 5, 2022
Cataract, Lens Opacities, Artificial Lens Implant Trial (Clinical Prototype BioBase (SN 07 and SN 08))
Not yet recruiting
- Cataract
- +5 more
- Clinical Prototype BioBase (SN 07 and SN 08)
- (no location specified)
Jul 12, 2022
Mesenchymal Stromal Cells, Cornea, Corneal Defect Trial (MSC Secretome Eye Drops)
Not yet recruiting
- Mesenchymal Stromal Cells
- +3 more
- MSC Secretome Eye Drops
- (no location specified)
Jan 11, 2022
Mesenchymal Stromal Cells, Cornea, Safety Trial in Chicago (Allogeneic MSC)
Recruiting
- Mesenchymal Stromal Cells
- +3 more
- Allogeneic MSC
-
Chicago, IllinoisUniversity of Illinois, Department of Ophthalmology and Visual S
Apr 19, 2022
Persistent Corneal Epithelial Defect Trial in United States (lufepirsen, Vehicle)
Recruiting
- Persistent Corneal Epithelial Defect
-
Pasadena, California
- +5 more
Jul 21, 2023
Persistent Corneal Epithelial Defect Trial in United States (KPI-012, KPI-012 Vehicle)
Recruiting
- Persistent Corneal Epithelial Defect
- KPI-012
- KPI-012 Vehicle
-
Louisville, Kentucky
- +5 more
Feb 13, 2023
Corneal Ulcer, Persistent Corneal Epithelial Defect Trial (LV-Visio-AMTRIX)
Withdrawn
- Corneal Ulcer
- Persistent Corneal Epithelial Defect
- LV-Visio-AMTRIX
- (no location specified)
Aug 2, 2022
Persistent Corneal Epithelial Defect Trial in Mexico City (KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75%
Recruiting
- Persistent Corneal Epithelial Defect
- KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75% (CMHA-S)
-
Mexico City, Chimalpopoca 14 Colonia Obrera, MexicoInstituto de Oftalmología Fundación Conde de Valenciana
Jul 6, 2022
Corneal Persistent Epithelial Defect Trial in Edgewood (NEXAGON High Dose Concentration, NEXAGON Low Dose Concentration, NEXAGON
Recruiting
- Corneal Persistent Epithelial Defect
- Nexagon® (lufepirsen) High Dose Concentration
- +3 more
-
Los Angeles, California
- +4 more
Aug 25, 2022
DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract
Completed
- Anterior Chamber Inflammation
- +7 more
- Dextenza 0.4Mg Ophthalmic Insert
-
Los Angeles, CaliforniaAdvanced Vision Care
Jul 14, 2021
Corneal Defect Trial in Shanghai (ZKY001 eye drops 0.3g:0.006mg, ZKY001 eye drops 0.3g:0.012mg, ZKY001 simulated eye drops)
Recruiting
- Corneal Defect
- ZKY001 eye drops 0.3g:0.006mg
- +2 more
-
Shanghai, Shanghai, ChinaEye & Ent Hospital of Fudan University
Sep 16, 2021
Corneal Defect Trial in Beijing (Germinal peptide eye drops)
Completed
- Corneal Defect
- Germinal peptide eye drops
-
Beijing, ChinaXiuli Zhao
Sep 16, 2021
Persistent Epithelial Defect Trial in Monterrey (PRP plus BCL, BCL plus PFL, Eye patch plus ocular lubricant ointment)
Recruiting
- Persistent Epithelial Defect
- PRP plus BCL
- +2 more
-
Monterrey, Nuevo Leon, MexicoDepartamento de Oftalmologia, Hospital Universitario "Dr. Jose E
May 16, 2022
Corneal Epithelial Defect Trial in Riyadh (Amniotic membrane transplantation, Autologous serum/BSS 20%)
Completed
- Corneal Epithelial Defect
- Amniotic membrane transplantation
- Autologous serum/BSS 20%
-
Riyadh, Saudi ArabiaKing Khaled Eye Specialist Hospital
Nov 21, 2021
Corneal Edema, Corneal Defect, Corneal Transplant Trial in Los Angeles (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate
Recruiting
- Corneal Edema
- +5 more
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
-
Los Angeles, CaliforniaAdvanced Vision Care
Dec 23, 2020
Results in Neurotrophic Keratopathy in Stages 2 and 3
Completed
- Corneal Ulcer
- +3 more
- Topical Insulin
-
Vila Nova de Gaia, PortugalCentro Hospitalar Vila Nova de Gaia e Espinho
Apr 24, 2021
Persistent Corneal Epithelial Defect Trial in Amman (Platelet Lysate)
Completed
- Persistent Corneal Epithelial Defect
- Platelet Lysate
-
Amman, JordanCell Therapy Center
Mar 2, 2021
Persistent Corneal Epithelial Defect Trial in United States (ST266)
Completed
- Persistent Corneal Epithelial Defect
- ST266
-
Indianapolis, Indiana
- +7 more
Aug 13, 2021
Persistent Corneal Epithelial Defect Trial in United States (ST266, 0.67% Sodium Chloride Ophthalmic Solution, Open-label ST266)
Terminated
- Persistent Corneal Epithelial Defect
- ST266
- +2 more
-
Dothan, Alabama
- +30 more
Oct 24, 2022
Corneal Defect Trial in Beijing (Germinal peptide eye drops)
Completed
- Corneal Defect
- Germinal peptide eye drops
-
Beijing, ChinaXiuli Zhao
Jan 31, 2020
Photorefractive Keratectomy Trial in Isfahan (prepared drop of medroxy progestrone acetat 1%)
Completed
- Photorefractive Keratectomy
- prepared drop of medroxy progestrone acetat 1%
-
Isfahan, Iran, Islamic Republic of
- +1 more
Jul 26, 2023
Persistent Corneal Epithelial Defects, Dry Eye Trial (Autologous platelet rich plasma eye drops)
Not yet recruiting
- Persistent Corneal Epithelial Defects
- Dry Eye
- Autologous platelet rich plasma eye drops
- (no location specified)
Sep 16, 2022
Limbal Stem-cell Deficiency, Congenital Aniridia Trial in Minneapolis (transplantation of a Descemet's Membrane corneal onlay,
Not yet recruiting
- Limbal Stem-cell Deficiency
- Congenital Aniridia
- transplantation of a Descemet's Membrane corneal onlay, partial LSCD
- transplantation of a Descemet's Membrane corneal onlay, total/near-total LSCD
-
Minneapolis, MinnesotaUniversity of Minnesota
Jun 15, 2023
Neurotrophic Keratitis Trial in United States (rhNGF 20µg/ml, Placebo)
Completed
- Neurotrophic Keratitis
- rhNGF 20µg/ml
- Placebo
-
Loma Linda, California
- +11 more
Mar 31, 2022
Neurotrophic Keratitis Trial in Canada (Insulin, Tarsorrhaphy)
Recruiting
- Neurotrophic Keratitis
- Insulin
- Tarsorrhaphy
-
Edmonton, Alberta, Canada
- +5 more
Feb 2, 2023